Free tool
FAERS Monitor: Ventolin Hfa
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020983 or its brand name (Ventolin Hfa, Albuterol Sulfate). Reports on generic versions are filed under their own applications.
Reports
185,312
Serious
93,948
51% of reports
Hospitalization
44,905
Death reported
9,526
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- dyspnoea28,605
- wrong technique in product usage process18,262
- asthma17,594
- cough13,988
- drug ineffective13,804
- fatigue10,845
- pneumonia10,641
- headache10,172
- wheezing9,464
- no adverse event8,917
- off label use8,314
- nausea8,304
- device delivery system issue8,225
- pain7,981
- drug dose omission by device7,957
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 691 |
| 2005 | 683 |
| 2006 | 535 |
| 2007 | 558 |
| 2008 | 1,012 |
| 2009 | 1,163 |
| 2010 | 1,557 |
| 2011 | 2,314 |
| 2012 | 2,733 |
| 2013 | 2,937 |
| 2014 | 5,379 |
| 2015 | 8,729 |
| 2016 | 10,712 |
| 2017 | 10,791 |
| 2018 | 11,375 |
| 2019 | 12,933 |
| 2020 | 14,530 |
| 2021 | 14,317 |
| 2022 | 13,878 |
| 2023 | 16,402 |
| 2024 | 19,195 |
| 2025 | 18,830 |
| 2026 | 14,056 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,868,847 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| device delivery system issueSignal | 8,225 | 48.3 | 47.1 | 266,905 |
| wheezingSignal | 9,464 | 21.4 | 20.9 | 154,798 |
| asthmaSignal | 17,594 | 20.7 | 20.4 | 280,636 |
| drug dose omission by deviceSignal | 7,957 | 12.7 | 12.4 | 77,503 |
| wrong technique in product usage processSignal | 18,262 | 11.1 | 11.0 | 154,893 |
| dyspnoeaSignal | 28,605 | 6.0 | 5.9 | 115,943 |
| coughSignal | 13,988 | 5.9 | 5.8 | 54,890 |
| no adverse eventSignal | 8,917 | 5.8 | 5.7 | 34,159 |
| pneumoniaSignal | 10,641 | 3.8 | 3.8 | 21,787 |
| headache | 10,172 | 1.9 | 1.8 | 4,066 |
| fatigue | 10,845 | 1.6 | 1.6 | 2,425 |
| pain | 7,981 | 1.5 | 1.4 | 1,267 |
| nausea | 8,304 | 1.2 | 1.2 | 266 |
| drug ineffective | 13,804 | 1.2 | 1.2 | 445 |
| off label use | 8,314 | 1.1 | 1.1 | 49 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.